Search Results for: BIOTHERAPEUTICS DEVELOPMENT The Role of
Articles
June 6, 2018
RedShiftBio Launches New Protein Characterization Instrument System June 6, 2018
RedShift™ BioAnalytics, Inc. (RedShiftBio™) unveiled the AQS3™pro, a new protein characterization platform with powerful, integrated bioanalytics software that delivers automated, high sensitivity spectroscopic analysis for the development, formulation and manufacture of biotherapeutics.
May 18, 2015
Selecta Biosciences Makes Two Major Announcements May 18, 2015
Selecta Biosciences, Inc. recently announced that, under the terms of an existing strategic global collaboration, Sanofi has exercised its option...
March 30, 2015
Bellerophon Therapeutics Selects Flextronics to Manufacture Next-Generation Device March 30, 2015
Bellerophon Therapeutics, Inc. recently announced it has selected Flextronics International Ltd. as its manufacturing partner for the INOpulse Mark2, the...
January 3, 2013
1/9/2013 January 3, 2013
Ultragenyx Secures $75 Million for Ultra-Rare Diseases Ultragenyx Pharmaceutical Inc. recently announced the successful completion of a $75-million Series B...
August 26, 2012
8/29/2012 August 26, 2012
Synergy Pharmaceuticals Acquires BMS Drug Synergy Pharmaceuticals Inc. recently announced it has signed an Asset Purchase Agreement with Bristol-Myers Squibb...
August 12, 2012
8/15/2012 August 12, 2012
Quintiles Acquires Company to Advance Personalized Medicine Quintiles recently announced the acquisition of Expression Analysis, Inc. (EA), a premier provider...
June 25, 2012
6/27/2012 June 25, 2012
Hovione Reports Significant Sales Growth Hovione recently announced that the consolidated sales for the fiscal year ended March 2012 amounted...
March 15, 2012
3/20/2012 March 15, 2012
Connell Brothers Signs Agreement With World's Top Chemical Company Connell Brothers Australasia recently announced it was appointed by BASF Australia,...
February 12, 2012
2/14/2012 February 12, 2012
Bend Research Signs License Agreement With Eli Lilly & Company Bend Research Inc., a leading independent drug formulation development and...
November 3, 2011
11/8/2011 November 3, 2011
Gateway Analytical Growth Demands Move to a Larger Facility Gateway Analytical recently announced the company will move to a larger...
November 3, 2011
GSK to Use Alnylam Pharmaceuticals' RNAi Technology for Vaccine Production November 3, 2011
Alnylam Pharmaceuticals, Inc. recently announced it has formed a collaboration with GSK focused on Alnylam's VaxiRNA technology for certain GSK...
October 13, 2011
10/17/2011 October 13, 2011
Oncobiologics Announces Two New Agreements Worth Almost $80 Million Oncobiologics recently announced it has signed two major agreements. The first...
April 25, 2011
Precision NanoSystems & Alnylam Form New Delivery Collaboration April 25, 2011
Precision NanoSystems, Inc. and Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, recently announced the two companies have formed an...
April 19, 2011
4/26/2011 April 19, 2011
Precision NanoSystems & Alnylam Form New Delivery Collaboration Precision NanoSystems, Inc. and Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company,...
